EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity
Article in British Journal of Cancer (January 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in British Journal of Cancer (January 2024)
Article in Diagnostics (October 2023)
Article in Cancer Letters (August 2023)